Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques

NCT ID: NCT05830903

Last Updated: 2023-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Establish a novel vocational training program and test its validity in a pilot study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

40 schizophrenia patients will be recruited to join the virtual reality based vocational training program, the training effect will be compared by interview skills and problem solving before and after the training.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mild ED/NS

10 patients with mild or none executive function impairment and mild or none negative symptoms.

Group Type EXPERIMENTAL

VR-assisted occupational training

Intervention Type BEHAVIORAL

VR-assisted occupational training

Mild ED/Severe NS

10 patients with mild or none executive function impairment and severe or moderate negative symptoms.

Group Type EXPERIMENTAL

VR-assisted occupational training

Intervention Type BEHAVIORAL

VR-assisted occupational training

Severe ED/Mild NS

10 patients with severe or moderate executive function impairment and mild or none negative symptoms.

Group Type EXPERIMENTAL

VR-assisted occupational training

Intervention Type BEHAVIORAL

VR-assisted occupational training

Severe ED/NS

10 patients with severe or moderate executive function impairment and severe or moderate negative symptoms.

Group Type EXPERIMENTAL

VR-assisted occupational training

Intervention Type BEHAVIORAL

VR-assisted occupational training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VR-assisted occupational training

VR-assisted occupational training

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a diagnosis of schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders -5th version
* Aged between 20 and 55 years.
* Motivated to have a job.
* Having a full-scale IQ \> 70 on the Wechsler Adult Intelligence Scale-version IV.
* Having a PANSS positive scale \< 70, indicating a stable condition during the illness course.

Exclusion Criteria

* Comorbid with other major psychiatric disorders (i.e., bipolar disorders) or neurological diseases.
* Substance abuse within one year.
* Visual impairment and/or hearing impairment that would preclude participation in the VR-based training program.
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Taiwan University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yi Ling Chien

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Taiwan University Hospital

Taipei, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yi Ling Chien

Role: CONTACT

886-2-2312-3456 ext. 66013

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yi Ling Chien, M.D., Ph.D.

Role: primary

886-2-2312-3456 ext. 66013

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201904105RINB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.